Skip to main content
. 2018 Mar 20;138(3):627–636. doi: 10.1007/s11060-018-2831-7

Table 3.

Post-protocol treatments

RT/TMZ (n = 39) RT/TMZ/IFNβ (n = 39)
1. Same as protocol treatment 11 14
 TMZ 9 5
 TMZ + IFNβ 2 9
2. Other chemotherapy (ACNU, Irinotecan, ICE, other TMZ regimens) 1 6
3.SRS, SRT 4 7
4. Surgery 18 11
5. Others 5 1
 Bevacizumab 3 0
 Vaccine 2 1